Safety & Tolerability Study of CTP-499 in Patients With Moderate Chronic Kidney Disease

NCT01460199 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage 3 Chronic Kidney Disease

Interventions

DRUG: CTP-499
DRUG: placebo

Sponsor

Concert Pharmaceuticals